KFF Analysis: Prices for Many Brand-Name TrumpRx Drugs Are Cheaper Than the Average Price in Other Wealthy Countries, But Are Almost as Likely To Be More Expensive
September 26, 2026
September 26, 2026
SAN FRANCISCO, California, Sept. 26 (TNSrep) -- KFF, an organization that says it is an independent source of health policy analysis, polling and in-depth news coverage, issued the following news release:
* * *
Analysis: Prices for Many Brand-Name TrumpRx Drugs Are Cheaper than the Average Price in Other Wealthy Countries, But Are Almost as Likely To Be More Expensive
Sep 24, 2026
Consumers who buy brand-name prescription drugs without an avail . . .
* * *
Analysis: Prices for Many Brand-Name TrumpRx Drugs Are Cheaper than the Average Price in Other Wealthy Countries, But Are Almost as Likely To Be More Expensive
Sep 24, 2026
Consumers who buy brand-name prescription drugs without an avail . . .